Exclusive: SoftBank leads latest Alto Pharmacy funding round at over $1 billion valuation

SoftBank's second Vision Fund has led a new round of funding for Silicon Valley-based drug delivery firm Alto Pharmacy that valued it at over $1 billion, according to two people familiar with the development.